VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $602 | -7.0% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $647 | -99.5% | 20 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $134,000 | +4.7% | 5,000 | 0.0% | 0.15% | +2.1% |
| Q2 2019 | $128,000 | +14.3% | 5,000 | 0.0% | 0.15% | +22.7% |
| Q1 2019 | $112,000 | +6.7% | 5,000 | 0.0% | 0.12% | -3.3% |
| Q4 2018 | $105,000 | +5.0% | 5,000 | 0.0% | 0.12% | +25.5% |
| Q3 2018 | $100,000 | -8.3% | 5,000 | 0.0% | 0.10% | -5.8% |
| Q2 2018 | $109,000 | -4.4% | 5,000 | 0.0% | 0.10% | +4.0% |
| Q1 2018 | $114,000 | -5.0% | 5,000 | 0.0% | 0.10% | -7.4% |
| Q4 2017 | $120,000 | +69.0% | 5,000 | +66.7% | 0.11% | +54.3% |
| Q3 2017 | $71,000 | +9.2% | 3,000 | 0.0% | 0.07% | +1.4% |
| Q2 2017 | $65,000 | -12.2% | 3,000 | 0.0% | 0.07% | -18.8% |
| Q1 2017 | $74,000 | -1.3% | 3,000 | 0.0% | 0.08% | -17.5% |
| Q3 2016 | $75,000 | – | 3,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |